{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-038295","form_type":"8-K","ticker":"YCBD","cik":"0001644903","company_name":"cbdMD, Inc.","filed_at":"2024-12-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.083362+00:00","generated_at":"2026-05-28T23:38:27.018637+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"cbdMD appoints CEO/CFO Ronan Kennedy to Board, expanding to 5 members","bullets":["Expanded Board from 4 to 5; Kennedy appointed effective Dec 18/19, 2024.","Kennedy will not receive additional compensation for board service.","Three of five Board members meet independence standards; Kennedy is not independent.","Kennedy's term expires at the 2025 annual shareholder meeting; he will not serve on committees.","Press release highlights Kennedy's role in cost optimization and cash position improvement."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-038295","json":"https://secwatch.observer/filing/0001437749-24-038295.json","markdown":"https://secwatch.observer/filing/0001437749-24-038295.md","text":"https://secwatch.observer/filing/0001437749-24-038295.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1644903/000143774924038295/0001437749-24-038295-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1644903/000143774924038295/ycbd20241223_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T23:38:27.018637+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}